Jeffrey Coleman

Popular Topics

Food, Drugs, Healthcare, Life Sciences Intellectual Property

DETAILS

United States

+1 212 7159100

AUTHORS CONTENT

Less Is More — The Premise Of The Biosimilar 'Patent Thicket' Bill

United States IP

Just Opt Out! Boehringer Ingelheim's IRA Challenge Is Latest To Fail

United States Healthcare

Potential Effects Of The Inflation Reduction Act On Orphan Drug Development

United States Healthcare

Exploring The Amgen Genus Claims Headed To High Court

United States Healthcare

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More